Impedimed Limited Issues Shares to Non-Executive Directors

An update from Impedimed Limited ( (AU:IPD) ) is now available.

Impedimed Limited announced the issuance of 942,353 ordinary fully paid shares to its non-executive directors as part of the Non-Executive Director Share Plan, covering 30% of director fees for the quarter ending March 31, 2025. This move is part of the company’s strategy to align the interests of its directors with shareholders, potentially impacting the company’s governance and financial structure.

More about Impedimed Limited

Impedimed Limited operates in the medical technology industry, focusing on developing and providing non-invasive medical devices. The company’s primary products are designed for the measurement and monitoring of fluid status and body composition, with applications in healthcare sectors such as oncology and cardiology.

YTD Price Performance: -50.0%

Average Trading Volume: 72,592

Technical Sentiment Signal: Buy

Current Market Cap: $44.05M

See more data about IPD stock on TipRanks’ Stock Analysis page.